You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Alembic Pharmaceuticals Ltd"

Alembic Pharmaceuticals Ltd Alembic Pharmaceuticals Limited receives USFDA Approval for Telmisartan and Amlodipine Tablets

  • 18/11/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Outcome of Board Meeting

  • 25/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Announces Q2 Results (Standalone & Consolidated) Limited Review Report (Standalone & Consolidated) R

  • 25/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

  • 21/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Updates

  • 20/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Schedule of Post Results Conferece Call

  • 17/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation

  • 13/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Q2 results on Oct 25 2016

  • 12/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Updates

  • 05/10/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Outcome of AGM

  • 30/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 30/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Announces Q1 (Standalone & Consolidated) results Limited Review Report (Standalone & Consolidated) R

  • 29/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Schedule of Post Results Conference Call

  • 21/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Q1 results on July 29 2016

  • 11/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Updates

  • 08/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended J

  • 08/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Alembic Pharmaceuticals receives USFDA Tentative Approval for Febuxostat Tablets

  • 05/07/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd USFDA Audit

  • 30/06/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd AGM on July 29 2016

  • 21/06/2016
  • |
  • bse

Alembic Pharmaceuticals Ltd Fixes Book Closure for Dividend & AGM

  • 21/06/2016
  • |
  • bse

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard